J. Vaamonde

1.3k total citations
45 papers, 898 citations indexed

About

J. Vaamonde is a scholar working on Neurology, Cellular and Molecular Neuroscience and Rheumatology. According to data from OpenAlex, J. Vaamonde has authored 45 papers receiving a total of 898 indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Neurology, 11 papers in Cellular and Molecular Neuroscience and 7 papers in Rheumatology. Recurrent topics in J. Vaamonde's work include Neurological disorders and treatments (29 papers), Parkinson's Disease Mechanisms and Treatments (22 papers) and Botulinum Toxin and Related Neurological Disorders (14 papers). J. Vaamonde is often cited by papers focused on Neurological disorders and treatments (29 papers), Parkinson's Disease Mechanisms and Treatments (22 papers) and Botulinum Toxin and Related Neurological Disorders (14 papers). J. Vaamonde collaborates with scholars based in Spain, United Kingdom and Argentina. J. Vaamonde's co-authors include M. R. Luquín, José Á. Obeso, Julio Artieda, J. A. Obeso, G. Lera, Oscar S. Gershanik, Francisco Grandas, M. Rodriguez, J. M. Martínez‐Lage and M. E. Guerra Rodríguez and has published in prestigious journals such as SHILAP Revista de lepidopterología, Brain and Neurology.

In The Last Decade

J. Vaamonde

42 papers receiving 856 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. Vaamonde Spain 14 703 310 125 83 62 45 898
Joseph Jankovic United States 12 608 0.9× 290 0.9× 127 1.0× 91 1.1× 54 0.9× 15 813
Andreas Neophytides United States 19 649 0.9× 231 0.7× 211 1.7× 57 0.7× 71 1.1× 42 1.1k
W. Poewe Germany 15 478 0.7× 165 0.5× 123 1.0× 52 0.6× 13 0.2× 49 826
Jacob I. Sage United States 19 687 1.0× 233 0.8× 71 0.6× 20 0.2× 30 0.5× 37 933
F.W. Vreeling Netherlands 12 348 0.5× 139 0.4× 110 0.9× 38 0.5× 13 0.2× 22 638
G. J. A. Macphee United Kingdom 12 347 0.5× 164 0.5× 205 1.6× 20 0.2× 40 0.6× 24 746
Stuart Perlik United States 13 217 0.3× 168 0.5× 171 1.4× 20 0.2× 51 0.8× 16 575
Olga Waln United States 9 388 0.6× 163 0.5× 156 1.2× 35 0.4× 31 0.5× 17 528
Marlene Alonso-Juárez Mexico 12 218 0.3× 81 0.3× 111 0.9× 83 1.0× 45 0.7× 34 433
Gail A. Kang United States 12 571 0.8× 249 0.8× 74 0.6× 20 0.2× 16 0.3× 16 716

Countries citing papers authored by J. Vaamonde

Since Specialization
Citations

This map shows the geographic impact of J. Vaamonde's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Vaamonde with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Vaamonde more than expected).

Fields of papers citing papers by J. Vaamonde

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Vaamonde. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Vaamonde. The network helps show where J. Vaamonde may publish in the future.

Co-authorship network of co-authors of J. Vaamonde

This figure shows the co-authorship network connecting the top 25 collaborators of J. Vaamonde. A scholar is included among the top collaborators of J. Vaamonde based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Vaamonde. J. Vaamonde is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
García‐Carpintero, Sonia, Javier Frontiñán-Rubio, Mariano Amo‐Salas, et al.. (2021). Ubiquinol Supplementation Improves Gender-Dependent Cerebral Vasoreactivity and Ameliorates Chronic Inflammation and Endothelial Dysfunction in Patients with Mild Cognitive Impairment. Antioxidants. 10(2). 143–143. 8 indexed citations
2.
Vaamonde, J., et al.. (2018). Osteoporosis. Medicine - Programa de Formación Médica Continuada Acreditado. 12(69). 4062–4074.
3.
Gallardo, María José, et al.. (2014). Patients with advanced Parkinson's disease with and without freezing of gait: A comparative analysis of vascular lesions using brain MRI. SHILAP Revista de lepidopterología. 29(4). 218–223. 7 indexed citations
4.
5.
Vaamonde, J., et al.. (2009). The duration of the motor response to apomorphine boluses is conditioned by the length of a prior infusion in Parkinson's disease. Movement Disorders. 24(5). 762–766. 6 indexed citations
6.
Vaamonde, J., et al.. (2007). Subacute hemicorporal parkinsonism in 5 patients with infarcts of the basal ganglia. Journal of Neural Transmission. 114(11). 1463–1467. 8 indexed citations
7.
Vaamonde, J., et al.. (2005). SPECT con 123I-IBZM: utilidad en el diagnóstico diferencial de parkinsonismos degenerativos y establecimiento de un método de cuantificación. Revista Española de Medicina Nuclear. 24(4). 234–243. 2 indexed citations
8.
Vaamonde, J., et al.. (2004). [Study of the pre and post-synaptic dopaminergic system by DaTSCAN/IBZM SPECT in the differential diagnosis of parkinsonism in 75 patients].. PubMed. 19(6). 292–300. 9 indexed citations
9.
Jiménez‐Jiménez, Félix Javier, María José Catalán, Antonio Vázquez, et al.. (1997). Delayed-onset dystonia in patients with antecedents of perinatal asphyxia. Parkinsonism & Related Disorders. 3(1). 21–25. 4 indexed citations
10.
Larumbe, R, J. Vaamonde, Julio Artieda, J. L. Zubieta, & J. A. Obeso. (1993). Reflex blepharospasm associated with bilateral basal ganglia lesion. Movement Disorders. 8(2). 198–200. 25 indexed citations
11.
Luquín, M. R., et al.. (1992). Levodopa‐induced dyskinesias in Parkinson's disease: Clinical and pharmacological classification. Movement Disorders. 7(2). 117–124. 172 indexed citations
12.
Obeso, José Á., et al.. (1992). Motor Response to Repeated Dopaminergic Stimulation in Parkinsonʼs Disease. Clinical Neuropharmacology. 15(1). 75–75. 10 indexed citations
13.
Vaamonde, J., Julio Artieda, & José Á. Obeso. (1991). Hereditary paroxysmal ataxia with neuromyotonia. Movement Disorders. 6(2). 180–182. 21 indexed citations
14.
Vaamonde, J., M. R. Luquín, & José Á. Obeso. (1991). SUBCUTANEOUS LISURIDE INFUSION IN PARKINSON'S DISEASE. Brain. 114(1). 601–614. 72 indexed citations
15.
Vaamonde, J., M. R. Luquín, & J. A. Obeso. (1990). Dopaminergic responsiveness to apomorphine after chronic treatment with subcutaneous lisuride infusion in Parkinson's disease. Movement Disorders. 5(3). 260–262. 11 indexed citations
16.
Vaamonde, J., M. R. Luquín, & José Á. Obeso. (1989). Levodopa Consumption Reduces Dopaminergic Receptor Responsiveness in Parkinsonʼs Disease. Clinical Neuropharmacology. 12(4). 271–284. 13 indexed citations
17.
Luquín, M. R., J. Vaamonde, & José Á. Obeso. (1989). Levodopa and 3-O-Methyldopa Plasma Levels in Parkinsonian Patients with Stable and Fluctuating Motor Response. Clinical Neuropharmacology. 12(1). 46–54. 12 indexed citations
18.
Obeso, José Á., et al.. (1988). Subcutaneous administration of lisuride in the treatment of complex motor fluctuations in Parkinson’s disease. PubMed. 27. 17–25. 8 indexed citations
19.
Obeso, José Á., Julio Artieda, N. Quinn, et al.. (1988). Piracetam in the Treatment of Different Types of Myoclonus. Clinical Neuropharmacology. 11(6). 529–536. 42 indexed citations
20.
Obeso, José Á., et al.. (1987). Continuous Dopaminergic Stimulation in Parkinson's Disease. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 14(S3). 488–492. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Joseph Jankovic Breakdown of academic impact, for papers by Andreas Neophytides Breakdown of academic impact, for papers by W. Poewe Breakdown of academic impact, for papers by Jacob I. Sage Breakdown of academic impact, for papers by F.W. Vreeling Breakdown of academic impact, for papers by G. J. A. Macphee Breakdown of academic impact, for papers by Stuart Perlik Breakdown of academic impact, for papers by Olga Waln Breakdown of academic impact, for papers by Marlene Alonso-Juárez Breakdown of academic impact, for papers by Gail A. Kang
Rankless by CCL
2026